ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pulmonary"

  • Abstract Number: L07 • ACR Convergence 2024

    The Classification Criteria for Anti-Synthetase Syndrome (Class) Project

    Giovanni Zanframundo1, Sara Faghihi Kashani2, Akira Yoshida3, Eduardo Dourado4, Iazsmin Bauer Ventura5, Daphne Rivero Gallegos6, Aravinthan Loganathan7, Gianluca Sambataro8, Francisca Bozan9, Sangmee Bae10, Darosa Lim11, Marta Cheli12, Yasuhiko Yamano13, Francesco Bonella14, Tamera Corte15, Tracy J. Doyle16, David Fiorentino17, Miguel Gonzalez-Gay18, Marie Hudson19, Masataka Kuwana20, Ingrid Lundberg21, Andrew Mammen22, Neil McHugh23, Frederick Miller24, Carlomaurizio Montecucco1, Chester Oddis25, Jorge Rojas-Serrano6, Jens Schmidt26, Carlo Alberto Scirè27, Albert Selva-O'Callaghan28, Victoria Werth11, Davide Rozza29, Monica Morosini30, Sara Bozzini30, Lorenzo Cavagna1, Rohit Aggarwal25 and the CLASS project investigators, 1Università di Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 2University of Pittsburgh School of Medicine, Pittsburgh, PA, USA and University of California, San Francisco, CA, 3Nippon Medical School Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan, 4Unidade Local de Saùde da Regiao de Aveiro and Aveiro Rheumatology Research Centre, Aveiro, Portugal; Universidade de Lisboa, Lisboa, Portugal, 5University of Chicago, Chicago, IL, 6Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico City, Mexico, 7Royal National Hospital for Rheumatic Diseases and University of Bath, UK; Arthritis Australia, Broadway, Glebe, NSW, Australia, 8University of Enna "Kore", Enna, Italy, 9Hospital Clinico Universidad de Chile, Santiago de Chile, Chile, 10UCLA, Los Angeles, CA, 11University of Pennsylvania, Philadelphia, PA, 12Fondazione IRCCS Istituto Neurologico C. Besta, Milano, Italy, 13Tosei General Hospital, Aichi, Japan, 14University of Duisburg-Essen, Essen, Germany, 15Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia, 16Brigham and Women's Hospital, Boston, MA, 17Stanford University, Redwood City, CA, 18IIS-Fundación Jiménez Díaz, Madrid, Spain, 19McGill University, Montreal, QC, Canada, 20Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 21Karolinska Institutet, Stockholm, Sweden, 22NIH, Bethesda, MD, 23University of Bath, Bath, United Kingdom, 24NIH, NIEHS, Durham, NC, 25University of Pittsburgh, Pittsburgh, PA, 26University Medical Center Goettingen, Goettingen, Germany, 27Univeristy of Milano Bicocca, Milan, Italy and IRCCS San Gerardo dei Tintori Foundation, Monza, Italy, 28Hospital Universitari Vall d'Hebron, Barcelona, Spain, 29Italian Society for Rheumatology, Milano, Italy, 30Fondazione IRCCS Policlinico San Matteo Hospital of Pavia, Pavia, Italy

    Background/Purpose: The aim of this study was to develop and validate new classification criteria for Anti-Synthetase Syndrome (ASSD) using data and consensus driven methodologies and…
  • Abstract Number: 0953 • ACR Convergence 2024

    Establishment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension Specific Endothelial Cells Through iPSCs and Their Functional and Molecular Analyses

    Yuki Kudo1, Masaru Kato1, Yuhei Shibata2, Ryo Hisada1, Michihito Kono1, Yuichiro Fujieda1, Olga Amengual3 and Tatsuya Atsumi1, 1Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, Sapporo, Japan, 2Rheumatology Department, Hokkaido Medical Center for Rheumatic Diseases, Sapporo, Japan., Sapporo, Japan, 3Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan

    Background/Purpose: Systemic sclerosis associated pulmonary arterial hypertension (SSc-PAH) is of particularly clinical interest since its outcomes remain unfavorable despite modern PAH therapies. Previous reports showed…
  • Abstract Number: 1894 • ACR Convergence 2024

    Detection of Fibrotic Lung Changes and Bronchiectasis in RA Patients Screened for Lung Cancer with Low-dose CT Chest: Results from a Large Multi-hospital System

    Gregory McDermott1, Mark Hammer2, Xiaosong Wang3, Misti Paudel4, Sung Hae Chang5, Pierre-Antoine Juge6, Qianru Zhang7, Jessica Lorusso8, Amie Samulyov8, Kathleen Vanni2, Alene Saavedra2, Emily Kowalski2, Grace Qian3, Katarina Bade2, Kevin Mueller2, Jeffrey Sparks9 and Suzanne Byrne2, 1Brigham and Women's Hospital, Brookline, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women’s Hospital, Boston, MA, 4Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity, Boston, MA, 5Soonchunhyang University College of Medicine, Bongmyeong-dong, Dongnam-gu, Cheonan-si, South Korea, 6Departement of Rheumatology, AP-HP, Bichat Hospital, Boston, MA, 7Harard Medical School, Cambridge, 8Mass General Brigham, Boston, MA, 9Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA

    Background/Purpose: Cigarette smoking is a risk factor for both lung cancer and RA. Furthermore, RA is associated with pulmonary abnormalities including interstitial lung disease, bronchiectasis,…
  • Abstract Number: 0154 • ACR Convergence 2024

    Chronic Sinusitis Predicting Interstitial Lung Disease in Sjögren’s Syndrome: A Comprehensive USA Population Study (2004-2024)

    Brian Schonewald1, Ross summer2, Giorgos Loizidis2 and Christopher Xie3, 1Thomas Jefferson University Hospital, Ardmore, PA, 2Thomas Jefferson University, Philadelphia, PA, 3Thomas Jefferson University, Philadelphia

    Background/Purpose: Sjögren's syndrome (SS) is a chronic autoimmune disorder primarily affecting the exocrine glands, but it also impacts various parts of the respiratory system, including…
  • Abstract Number: 0956 • ACR Convergence 2024

    Secreted Frizzled-Related Protein 2 (sFRP2) Regulates Wnt Signaling to Affect Mesenchymal Transition of Lung Epithelial Cells Participates in Interstitial Lung Disease

    Yinlan Wu1, Yanhong Li2 and Yi Liu3, 1West China Hospital of Sichuan University, Chengdu, Sichuan, China, 2West China School of Medicine and West China Hospital, Sichuan University, Cheng Du, Sichuan, China, 3West China Hospital, Sichuan University, Chengdu, China (People's Republic)

    Background/Purpose: Investigation of Transcriptional Changes in Interstitial Lung Disease (ILD) and Exploration of Functional Effects of Differential Genes and Expressed Proteins in the Development of…
  • Abstract Number: 1976 • ACR Convergence 2024

    Artificial Intelligence Analysis of HRCT Images Reflects Pulmonary Involvement in Systemic Sclerosis Interstitial Lung Disease

    Enrico De Lorenzis1, Lucy Elizabeth Thornton2, Stefano Di Donato3, Marco Minerba3, Lesley-Anne Bissell4, Riccardo Bixio5, Anand Devaraj6, Peter George7 and Francesco Del Galdo8, 1Catholic University of the Sacred Heart, Roma, Rome, Italy, 21. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, 2. NIHR Leeds Biomedical Research Centre, United Kingdom, Leeds, 31. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, 2. NIHR Leeds Biomedical Research Centre, United Kingdom, Leeds, United Kingdom, 4Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 5University of Verona, Verona, Verona, Italy, 6Department of Radiology, Royal Brompton Hospital, London, London, United Kingdom, 7Department of Interstitial Lung Disease, Royal Brompton Hospital London, London, United Kingdom, 8University of Leeds, Leeds, United Kingdom

    Background/Purpose: Interstitial lung disease (ILD) is the leading cause of mortality and morbidity in systemic sclerosis (SSc) patients. Current functional, imaging, and clinical measures of…
  • Abstract Number: 0253 • ACR Convergence 2024

    Outcomes of Respiratory Syncytial Virus Infection in Patients with Systemic Autoimmune Rheumatic Diseases

    Justine Enns1, Shruthi Srivatsan1, Bohang Jiang1, Miao Lin1, Emily Kowalski2, Naomi Patel1, Xiaosong Wang3, Zachary Williams1, Grace Qian3, Jennifer Hanberg1, Colebrook Johnson1, Madison Negron1, Katarina Bade2, Alene Saavedra2, Kevin Mueller2, Kathleen Vanni3, Jeffrey Sparks4 and Zachary Wallace5, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women’s Hospital, Boston, MA, 4Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA, 5Massachusetts General Hospital, Newton, MA

    Background/Purpose: Respiratory Syncytial Virus (RSV) can cause a severe respiratory illness, especially in older adults and those with significant comorbidities. In June 2023 the US…
  • Abstract Number: 0993 • ACR Convergence 2024

    Pulmonary Complications and Mortality Trends in Rheumatoid Arthritis Patients Aged 65 and Older in the United States: A CDC WONDER Database Analysis

    Muhammad Naveed1, Rabia Iqbal1, Kishan Patel2, Ahila Ali1, Simran Bhimani3, Bazil Azeem4, Yash Deshpande3, Muhammad Omer Rehan1, Faizan Ahmed5, Hussain Haider Shah1 and Nouman Shafique6, 1Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan, 2Riverside Community Hospital, Riverside, CA, 3The Wright Center for graduate medical education, Scranton, PA, 4Shaheed Mohtarma Benazir Bhutto Medical College Liyari, Karachi, Pakistan, 5Ameer-ud-Din Medical College, Lahore, Pakistan, 6AdventHealth Orlando, Orlando, FL

    Background/Purpose: Pulmonary complications in rheumatoid arthritis (RA) are an important cause of mortality among older adults. This study analyzes trends and demographic disparities in mortality…
  • Abstract Number: 2034 • ACR Convergence 2024

    Effectiveness and Tolerability of Tocilizumab in Systemic Autoimmune Rheumatic Disease Associated Intertistial Lung Disease

    Anne Dupont1, Clairelyne Dupin2, Esther Ebstein1, Marine Forien1, Sébastien Ottaviani1, Pierre Le Guen2, Quentin Philippot2, Raphaël Borie2, Bruno Crestani3, Philippe Dieudé1 and Pierre-Antoine Juge4, 1Departement of Rheumatology, AP-HP, Bichat Hospital, Paris, France, 2National Reference Center for Rare Pulmonary Diseases, Department of Pulmonology, AP-HP, Bichat Hospital, Paris, France, 3National Reference Center for Rare Pulmonary Diseases, Department of Pulmonology, AP-HP, Bichat Hospital, Paris, Ile-de-France, France, 4Departement of Rheumatology, AP-HP, Bichat Hospital, Boston, MA

    Background/Purpose: Interstitial lung diseases (ILD) are severe manifestations of systemic autoimmune diseases (SARD) that are associated with an increased mortality. Although the primary endpoint was not…
  • Abstract Number: 0263 • ACR Convergence 2024

    Characteristics and Coinfections of Diffuse Alveolar Hemorrhage in Rheumatic Patients

    Eduardo Briones-García1, Shaul Navarro-Lara2, Marco A Ortiz-Bustamante2, Iris Paola García Herrera3, Carla M Roman-Montes2 and Guillermo A Guaracha-Basañez4, 1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Immunology and Rheumatology Department., Ciudad de México, Distrito Federal, Mexico, 2Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador-Zubirán., México city, Mexico, 3Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 4Instituto Nacional de Ciencias Medicas y Nutricion “Salvador Zubirán”, Mexico City, Distrito Federal, Mexico

    Background/Purpose: Diffuse alveolar hemorrhage (DAH) is a severe respiratory complication observed in certain rheumatic diseases, such as systemic lupus erythematosus (SLE), ANCA-associated vasculitides (AAV), and…
  • Abstract Number: 1070 • ACR Convergence 2024

    Evaluating & Improving Adherence to Pulmonary Hypertension Screening in Systemic Sclerosis Patients

    John Hickernell1 and Zineb Aouhab2, 1Loyola Univeristy Medical Center, Chicago, IL, 2Loyola University Medical Center, Oak Brook, IL

    Background/Purpose: Annual screening for pulmonary hypertension (PH) in patients with Systemic Sclerosis (SSc) has been shown to decrease mortality. The American College of Radiology, European…
  • Abstract Number: 2042 • ACR Convergence 2024

    Overview of Lung Manifestations in Sarcoidosis and Various Treatment Approaches at a University Center

    Aleeza Qamar1, Upasana Agrawal2, Karan Sachdeva3, Zara Hassan4, Alex Zamora1, Syeda Nida5, Sarwat Umer1, Samina Hayat1 and Kinza Muzaffar6, 1LSU Health-Shreveport, Shreveport, 2LSU Health, Shreveport, Shreveport, LA, 3Louisiana state university health shreveport LA, Shreveport, 4Louisiana State University Health Sciences, Shreveport, LA, 5LSU Healh-Shreveport, Shreveport, 6LSU HEALTH SHREVEPORT, SHREVEPORT, LA

    Background/Purpose: Sarcoidosis is a disease occurring in the form of non-caseating granulomas, with unclear etiology and multi-system manifestations. Pulmonary involvement in sarcoidosis is a cardinal…
  • Abstract Number: 0288 • ACR Convergence 2024

    Hypersensitivity Pneumonitis with Autoimmune Features: A New Entity?

    Pol Maymó1, Javier Narvaez-García2, Guadalupe Bermudo1, Vanesa Vicens-Zygmunt3, Santiago Bolivar4, Belen del Río5, Judith Palacios5, Martí Aguilar Coll2, Monserrat Roig Kim2, Laia De Daniel2, Paola Vidal1, Joan Miquel Nolla2 and María Molina1, 1Hospital Universtiario de Bellvitge, Barcelona, Spain, 2Hospital Universitario de Bellvitge, Barcelona, Spain, 3Hospital Universitario de Bellvitge., Barcelona, Spain, 4Bellvitge University Hospital, L'Hospitalet de Llobregat, Catalonia, Spain, 5Hospital Universtiario de Bellvitge, Hosptalet de Llobregat, Catalonia, Spain

    Background/Purpose: Hypersensitivity pneumonitis (HP) is an interstitial lung disease induced by inhaled antigens that trigger an interstitial and bronchoalveolar lymphocytic inflammatory response. This immune response…
  • Abstract Number: 1112 • ACR Convergence 2024

    Pleuroparenchymal Fibroelastosis Associated with Connective Tissue Diseases (PPFE-CTD)

    Maximiliano Diaz Menindez1, Alejandro Diaz Arumir Vergara2, Vivian Shing2, carolyn mead harvey3, Ana Zamora Martinez2 and Vivek Nagaraja4, 1Mayo Clinic School of Graduate Medical Education, Phoenix, AZ, 2Mayo Clinic, Phoenix, 3Mayo Clinic Florida, Jacksonville, FL, 4Mayo Clinic Arizona, Scottsdale, AZ

    Background/Purpose: Pleuroparenchymal Fibroelastosis (PPFE) is a rare idiopathic interstitial pneumonia characterized by fibrosis of the visceral pleura and subpleural parenchyma, predominantly affecting the upper lobes.…
  • Abstract Number: 2058 • ACR Convergence 2024

    Association of Anti-Synthetase Antibody Subtypes with Radiographic Progression of Interstitial Lung Disease in Anti-Synthetase Syndrome: An Analysis of the CLASS Project Database

    Daphne Rivero Gallegos1, Francisca Bozan2, Sangmee Bae3, Giovanni Zanframundo4, Sara Faghihi-Kashani5, Iazsmin Bauer Ventura6, Eduardo Dourado7, Gianluca sambataro8, Akira Yoshida9, Tamera J Corte10, Francesco Bonella11, Tracy J Doyle12, david fiorentino13, Miguel Angel Gonzalez-Gay14, marie Hudson15, Masataka Kuwana16, Antonella Notarnicola17, Andrew Mammen18, Neil McHugh19, Frederick Miller20, Carlomaurizio Montecucco21, Chester Oddis22, Jorge Rojas-Serrano23, Jens Schmidt24, Carlo A. Scire25, Albert Selva-O’Callaghan26, Victoria Werth27, Rohit Aggarwal28 and Lorenzo Cavagna29, and CLASS project participating investigators, 1INER, Ciudad de México, Mexico State, Mexico, 2Hospital Clinico Universidad de Chile, Santiago, Chile, 3UCLA, Los Angeles, CA, 4Università di Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, Milano, Italy, 5Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, San Francisco, CA, 6University of Chicago, Chicago, IL, 7Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal, 8University of Catania, Catania, Italy, 9Nippon Medical School Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan, 10Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia, 11Center for interstitial and rare lung diseases, Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany, 12Brigham and Women's Hospital, West Roxbury, MA, 13Department of Dermatology, Stanford University School of Medicine, Stanford, CA, Palo Alto, CA, 14University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 15McGill University, Montreal, QC, Canada, 16Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan, Tokyo, Japan, 17Karolinska University Hospital and Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 18NIH, Bethesda, MD, 19University of Bath, Bath, United Kingdom, 20NIH, NIEHS, Chapel Hill, NC, 21IRCCS policlinico S. Matteo foundation, University of Pavia, Pavia, Italy, 22Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 23National Institute of Respiratory Diseases, Ismael Cosío Villegas, Mexico City, Mexico, 24University Medical Center Goettingen, Göttingen, Germany, 25University of Milano Bicocca, Milan, Italy, 26Systemic Autoimmune Disease Unit, Vall d’Hebron Institute of Research, Barcelona, Spain, 27University of Pennsylvania, Wynnewood, PA, 28Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA, 29University of Pavia and Fondazione IRCCS Policlinico San Matteo Hospital of Pavia, Pavia, Pavia, Italy

    Background/Purpose: In anti-synthetase syndrome (ASSD), clinical presentations vary from isolated interstitial lung disease (ILD) to systemic multi-organ manifestations. Several studies emphasize the crucial role of…
  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology